Tag: FDA
FDA Wants More Sunscreen Regulations, but Would Consumers Get Burned?

Attempts to find “the right balance” are more likely to throw the sunscreen market wildly out of balance.

FDA Approves Record Number of Generic Drugs in 2018

With U.S. drug prices among the highest in the world, generics provide significant financial relief for millions using prescription drugs.

Teen Vaping Is Bad, but the Alternative Is Worse

The FDA’s efforts to reduce teen vaping rates will likely result in worse health outcomes by prompting teens to switch to smoking cigarettes.

Can the FDA Prevent Teens from Vaping?

Epidemics are causes for concern, but before we declare regulation to be the cure, we should question who administers the treatment.

Deregulation Is the Only Cure for High Drug Prices

The FDA’s influence in the prescription drug market remains the largest obstacle to deregulation.

To Help the Terminally Ill, the FDA Must Deregulate

Right-to-try will never reach its potential without deregulation.

FDA Struggles to Develop “Sugar Added” Labels for Honey and Maple Syrup

An example of sweet intentions bearing stale outcomes.

Let Competition, Not the FDA, Resolve the EpiPen Shortage

The only reliable remedy to mitigate shortages of any product is to allow competition in the market.

Three Reasons To Be Optimistic about Pharmaceutical Policy

Right-to-try, MDMA, and Epidolex provide examples of the power of public opinion to change the scope of government.

EpiPen Pricing Controversy Reveals Ignorance about Market Competition

Increased competition is the remedy to skyrocketing drug prices.

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org